Search Results - "GADDUCCI, Angiolo"
-
1
Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research
Published in Anticancer research (01-09-2020)“…Concurrent cisplatin-based chemotherapy and radiotherapy (CCRT) plus brachytherapy is standard treatment for locally advanced cervical cancer. Platinum-based…”
Get full text
Journal Article -
2
Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists
Published in Gynecologic oncology (01-03-2017)“…Abstract Neuroendocrine tumors (NET s ) are aggressive diseases developing from neuroendocrine cells that most frequently involve the gastro-entero-pancreatic…”
Get full text
Journal Article -
3
Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables
Published in Critical reviews in oncology/hematology (01-03-2019)“…Adenocarcinoma accounts for 10–25% of all cervical cancers, and its relative and absolute rate has raised over the past decades. Most, but not all the authors,…”
Get full text
Journal Article -
4
Endometriosis-associated Extraovarian Malignancies: A Challenging Question for the Clinician and the Pathologist
Published in Anticancer research (01-05-2020)“…Endometriosis is an estrogen-dependent disease, which affects 10% of women in the reproductive age. Malignant transformation is an uncommon event, which…”
Get full text
Journal Article -
5
Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes
Published in Gynecologic oncology (01-09-2021)“…Clear cell carcinoma of the ovary is a rare and distinct histotype of epithelial ovarian carcinomas. Women diagnosed with clear cell carcinomas are usually…”
Get full text
Journal Article -
6
Trabectedin and lurbinectedin: Mechanisms of action, clinical impact, and future perspectives in uterine and soft tissue sarcoma, ovarian carcinoma, and endometrial carcinoma
Published in Frontiers in oncology (03-11-2022)“…The ecteinascidins trabectedin and lurbinectedin are very interesting antineoplastic agents, with a favorable toxicity profile and peculiar mechanisms of…”
Get full text
Journal Article -
7
Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy
Published in Gynecologic oncology (01-06-2019)“…Placental site trophoblastic tumor [PSTT] and epithelioid trophoblastic tumor [ETT] are the rarest gestational trophoblastic neoplasias, developing from…”
Get full text
Journal Article -
8
Melanoma of the lower genital tract: Prognostic factors and treatment modalities
Published in Gynecologic oncology (01-07-2018)“…Primary melanomas originating from the gynecological tract are rare and aggressive cancers. The vulva is the most frequent site (70%), followed by vagina and…”
Get full text
Journal Article -
9
Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A challenging question for gynecologic oncologists
Published in Critical reviews in oncology/hematology (01-01-2019)“…Mature cystic teratomas of the ovary have an incidence of 1.2–14.2 cases per 100.000 people per year. Malignant transformation occurs in approximately 2% of…”
Get full text
Journal Article -
10
Pharmacological Treatment of Advanced, Persistent or Metastatic Endometrial Cancer: State of the Art and Perspectives of Clinical Research for the Special Issue "Diagnosis and Management of Endometrial Cancer"
Published in Cancers (07-12-2021)“…Patients with metastatic or recurrent endometrial cancer (EC) not suitable for surgery and/or radiotherapy are candidates for pharmacological treatment…”
Get full text
Journal Article -
11
Metformin use and gynecological cancers: a novel treatment option emerging from drug repositioning
Published in Critical reviews in oncology/hematology (01-09-2016)“…Highlights • Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added…”
Get full text
Journal Article -
12
Prognostic factors in uterine sarcoma
Published in Best practice & research. Clinical obstetrics & gynaecology (01-12-2011)“…Uterine sarcomas usually have an aggressive clinical behaviour, with great tendency to local and distant spread, with unfavourable clinical outcome, excluding…”
Get full text
Journal Article -
13
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
Published in Journal of ovarian research (28-01-2019)“…Epithelial ovarian cancer is the most lethal gynecologic malignancy. In most women, it is diagnosed at an advanced stage, which largely explains the poor…”
Get full text
Journal Article -
14
Perivascular epithelioid cell tumors (PEComa) of the female genital tract: A challenging question for gynaecologic oncologist and pathologist
Published in Gynecologic oncology reports (01-08-2020)“…•Perivascular epithelioid cell tumors (PEComa)s are mesenchymal neoplasms expressing both melanocytic and myogenic markers.•Gynecological PEComas account for…”
Get full text
Journal Article -
15
Factors in malignant transformation of ovarian endometriosis: A narrative review
Published in Gynecological endocrinology (01-12-2024)“…Endometriosis is a common estrogen-dependent inflammatory disease with a chronic course and a tendency to recur. The association between endometriosis and…”
Get full text
Journal Article -
16
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa’ italiana di Ginecologia E Ostetricia)
Published in European journal of cancer (1990) (01-11-2020)“…Uterine sarcomas are very rare tumours with different histotypes, molecular features and clinical outcomes; therefore, it is difficult to carry out prospective…”
Get full text
Journal Article -
17
Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study
Published in International journal of gynecological cancer (01-01-2017)“…The aim of this study was to assess the safety and efficacy of extending bevacizumab therapy beyond 15 months in nonprogressive ovarian cancer. In this…”
Get more information
Journal Article -
18
Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study
Published in Anticancer research (01-06-2018)“…To assess the patterns of recurrence and clinical outcomes of patients with cervical adenocarcinoma who underwent neoadjuvant platinum-based chemotherapy…”
Get full text
Journal Article -
19
A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab
Published in BMC urology (09-12-2019)“…The angiogenesis inhibitor monoclonal antibody Bevacizumab is presently the standard treatment for numerous neoplasms but particular toxicities are emerging,…”
Get full text
Journal Article -
20
Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma
Published in Frontiers in oncology (07-08-2023)Get full text
Journal Article